Glenn Mattes - Tff Pharmaceuticals CEO Pres
Insider
Glenn Mattes is CEO Pres of Tff Pharmaceuticals
| Age | 67 |
| Phone | 817 438 6168 |
| Web | https://tffpharma.com |
Tff Pharmaceuticals Management Efficiency
The company has return on total asset (ROA) of (1.0591) % which means that it has lost $1.0591 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (2.1351) %, meaning that it created substantial loss on money invested by shareholders. Tff Pharmaceuticals' management efficiency ratios could be used to measure how well Tff Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.Tff Pharmaceuticals currently holds 115.25 K in liabilities with Debt to Equity (D/E) ratio of 0.01, which may suggest the company is not taking enough advantage from borrowing. Tff Pharmaceuticals has a current ratio of 8.02, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Tff Pharmaceuticals' use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Scott Anderson | Anebulo Pharmaceuticals | N/A | |
| William Ho | In8bio Inc | 45 | |
| Sandra Esq | Immunome | 51 | |
| BSc FRCPath | INmune Bio | 59 | |
| David Hale | Dermata Therapeutics | 76 | |
| Matthew Robinson | Immunome | N/A | |
| Tomasz Kula | Tscan Therapeutics | N/A | |
| Paul MD | AN2 Therapeutics | 54 | |
| Stephen Elledge | Tscan Therapeutics | N/A | |
| Michael Hoffman | Annovis Bio | 69 | |
| Gordon JD | Quoin Pharmaceuticals Ltd | 61 | |
| MD FACP | AN2 Therapeutics | 77 | |
| Michael Myers | Quoin Pharmaceuticals Ltd | 63 | |
| Reid McCarthy | Annovis Bio | 66 | |
| Thomas Schlumpberger | Anixa Biosciences | N/A | |
| Eric Easom | AN2 Therapeutics | 57 | |
| DVM MS | Lantern Pharma | N/A | |
| Raymond MD | INmune Bio | 69 | |
| Kenneth Cundy | Anebulo Pharmaceuticals | 66 | |
| Gavin MacBeath | Tscan Therapeutics | 55 | |
| Joseph Zakrzewski | AN2 Therapeutics | 63 | |
Management Performance
| Return On Equity | -2.14 | ||||
| Return On Asset | -1.06 |
Tff Pharmaceuticals Leadership Team
Elected by the shareholders, the Tff Pharmaceuticals' board of directors comprises two types of representatives: Tff Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Tff. The board's role is to monitor Tff Pharmaceuticals' management team and ensure that shareholders' interests are well served. Tff Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Tff Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Harlan Weisman, Interim Chairman | ||
| Zamaneh MD, Chief Officer | ||
| Kirk Coleman, Treasurer CFO | ||
| Paul Manley, Head Affairs | ||
| Anthony Hickey, Chief Officer | ||
| Christopher Cano, COO Devel | ||
| Dale Christensen, Head Devel | ||
| Glenn Mattes, CEO Pres |
Tff Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Tff Pharmaceuticals a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -2.14 | ||||
| Return On Asset | -1.06 | ||||
| Operating Margin | (6.09) % | ||||
| Current Valuation | (2.27 M) | ||||
| Shares Outstanding | 4.44 M | ||||
| Shares Owned By Insiders | 3.31 % | ||||
| Shares Owned By Institutions | 24.37 % | ||||
| Number Of Shares Shorted | 157.16 K | ||||
| Price To Book | 0.09 X | ||||
| Price To Sales | 0.24 X |
Pair Trading with Tff Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Tff Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tff Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Adobe Systems could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Adobe Systems when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Adobe Systems - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Adobe Systems Incorporated to buy it.
The correlation of Adobe Systems is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Adobe Systems moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Adobe Systems moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Adobe Systems can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Consideration for investing in Tff Stock
If you are still planning to invest in Tff Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Tff Pharmaceuticals' history and understand the potential risks before investing.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Stocks Directory Find actively traded stocks across global markets | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |